Early results from an open-label phase 1b/II study of eribulin mesylate (EM) + pegvorhyaluronidase alfa (PEGHP20) combination for the treatment of patients with HER2-negative, high... von Shum, M., Assikis, V.J., Savulsky, C., Zhu, W., Iyer, P., Xing, D., Berman, C., Lokker, N.A., Alvarez, R.H.

Volltext

Generation and characterization of a competitive antagonist of human hepatocyte growth factor, HGF/NK1 von LOKKER, N. A, GODOWSKI, P. J

Volltext

Structure‐function analysis of hepatocyte growth factor: identification of variants that lack mitogenic activity yet retain high affinity receptor binding von Lokker, N.A., Mark, M.R., Luis, E.A., Bennett, G.L., Robbins, K.A., Baker, J.B., Godowski, P.J.

Volltext

Expression and characterization of hepatocyte growth factor receptor-IgG fusion proteins. Effects of mutations in the potential proteolytic cleavage site on processing and ligand b... von MARK, M. R, LOKKER, N. A, ZIONCHECK, T. F, LUIS, E. A, GODOWSKI, P. J

Volltext

Structure‐activity relationship study of human interleukin‐3: role of the C‐terminal region for biological activity von Lokker, N.A., Zenke, G., Strittmatter, U., Fagg, B., Movva, N.R.

Volltext

Structure-activity relationship study of human interleukin-3. Identification of residues required for biological activity by site-directed mutagenesis von LOKKER, N. A, MOVVA, N. R, STRITTMATTER, U, FAGG, B, ZENKE, G

Volltext